Randomized Phase II marker lesion study evaluating effect of scheduling on response to intravesical gemcitabine in recurrent Stage Ta urothelial cell carcinoma of the bladder
Keyword(s):
Phase Ii
◽
2012 ◽
Vol 30
(6)
◽
pp. 833-840
◽
Keyword(s):
2020 ◽
Vol 38
(8)
◽
pp. 685.e1-685.e10
◽
EpCAM Expression in Lymph Node Metastases of Urothelial Cell Carcinoma of the Bladder: A Pilot Study
2017 ◽
Vol 18
(8)
◽
pp. 1802
◽
2016 ◽
Vol 34
(15_suppl)
◽
pp. e16020-e16020
2015 ◽
Vol 194
(2)
◽
pp. 556-562
◽